UBS: Resumes Coverage on Regeneron Pharmaceuticals (REGN.US) with "Buy" Rating, Undervalues the Potential of Blockbuster Drug Dupixent
智通财经2026/10/15 06:46Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Zhihu Finance APP has learned that UBS has resumed coverage of Regeneron Pharmaceuticals (REGN.US) with a “Buy” rating and a target price of $978, which is about 30% higher than the latest closing price. Previously, the bank had assigned a “Neutral” rating to the stock.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Morgan Stanley raises mild winter TTF forecast to 90 euros per megawatt-hour
智通财经•2026/10/15 08:45
ByteDance is reportedly close to reaching an AI data center chip agreement with MediaTek, while Qualcomm, Broadcom, and Nvidia may come under pressure.
The share prices of Qualcomm (QCOM.US) and Broadcom (AVGO.US) have become the focus of the market after reports stated that ByteDance is close to reaching an agreement to purchase custom AI chips for data centers from Taiwan's MediaTek.
智通财经•2026/10/15 08:45
Crypto prices
More
Bitcoin
BTC
$81,224.03
-2.62%
Ethereum
ETH
$2,371.6
-5.43%
Tether USDt
USDT
$0.9987
-0.02%
BNB
BNB
$721.21
-2.86%
XRP
XRP
$1.32
-4.05%
USDC
USDC
$0.9999
-0.00%
Solana
SOL
$103.2
-3.67%
TRON
TRX
$0.3320
-0.17%
Hyperliquid
HYPE
$79.96
-1.69%
Zcash
ZEC
$1,111.94
-10.47%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now